
Michael S. Brooke
Examiner (ID: 8555)
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853 |
| Total Applications | 507 |
| Issued Applications | 449 |
| Pending Applications | 14 |
| Abandoned Applications | 44 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17065723
[patent_doc_number] => 20210267938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/952401
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952401 | MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF | Nov 18, 2020 | Abandoned |
Array
(
[id] => 18147585
[patent_doc_number] => 20230021442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => PHENOTHIAZINE FERROPTOSIS INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/778831
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778831 | Phenothiazine ferroptosis inhibitor, preparation method therefor and application thereof | Nov 17, 2020 | Issued |
Array
(
[id] => 17571059
[patent_doc_number] => 11319317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => (Hetero)arylamide compound for inhibiting protein kinase activity
[patent_app_type] => utility
[patent_app_number] => 17/098675
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15562
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098675
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098675 | (Hetero)arylamide compound for inhibiting protein kinase activity | Nov 15, 2020 | Issued |
Array
(
[id] => 16838329
[patent_doc_number] => 20210146341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => SUPPORTED COPPER CATALYST AND SELECTIVE HYDROGENATION OF FURAN-BASED COMPOUNDS USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/096835
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096835 | Supported copper catalyst and selective hydrogenation of furan-based compounds using the same | Nov 11, 2020 | Issued |
Array
(
[id] => 18207442
[patent_doc_number] => 20230053699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SUBSTITUTED-ISOXAZOLINE-CONTAINING AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/774814
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774814 | Substituted-isoxazoline-containing aromatic compound, preparation method therefor, herbicidal composition and use thereof | Nov 3, 2020 | Issued |
Array
(
[id] => 16612081
[patent_doc_number] => 20210030734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE
[patent_app_type] => utility
[patent_app_number] => 17/076069
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17076069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/076069 | METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE | Oct 20, 2020 | Abandoned |
Array
(
[id] => 16776459
[patent_doc_number] => 20210113536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHODS AND COMPOSITIONS FOR DETECTING AND TREATING VENOUS THROMBOEMBOLISM
[patent_app_type] => utility
[patent_app_number] => 17/075101
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075101 | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING VENOUS THROMBOEMBOLISM | Oct 19, 2020 | Abandoned |
Array
(
[id] => 17807342
[patent_doc_number] => 20220259177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/769783
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769783 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18109467
[patent_doc_number] => 20230002347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/769798
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769798 | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-YL)-2H-PYRAZOLE-3-CARBOXYLIC ACID | Oct 15, 2020 | Abandoned |
Array
(
[id] => 19904080
[patent_doc_number] => 12281076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Process for synthesis of picolinamides
[patent_app_type] => utility
[patent_app_number] => 17/754977
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16037
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754977 | Process for synthesis of picolinamides | Oct 14, 2020 | Issued |
Array
(
[id] => 17466693
[patent_doc_number] => 11273150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Compositions and methods for the treatment of presbyopia
[patent_app_type] => utility
[patent_app_number] => 17/069155
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 28235
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/069155 | Compositions and methods for the treatment of presbyopia | Oct 12, 2020 | Issued |
Array
(
[id] => 19081816
[patent_doc_number] => 20240108617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/754678
[patent_app_country] => US
[patent_app_date] => 2020-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754678 | AN INHALABLE DRY POWDER COMPOSITION FOR PULMONARY DISEASES | Oct 10, 2020 | Abandoned |
Array
(
[id] => 17990126
[patent_doc_number] => 20220356163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SMALL MOLECULE INHIBITORS OF Id PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/766027
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766027 | SMALL MOLECULE INHIBITORS OF Id PROTEINS | Sep 29, 2020 | Pending |
Array
(
[id] => 16582756
[patent_doc_number] => 20210017158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/033347
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 487
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/033347 | Bradykinin B2 receptor antagonists | Sep 24, 2020 | Issued |
Array
(
[id] => 16557080
[patent_doc_number] => 20210002228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
[patent_app_type] => utility
[patent_app_number] => 17/031196
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031196 | Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | Sep 23, 2020 | Abandoned |
Array
(
[id] => 16824197
[patent_doc_number] => 20210139490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/024095
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024095 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | Sep 16, 2020 | Abandoned |
Array
(
[id] => 17513666
[patent_doc_number] => 11292795
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Purinone derivative hydrochloride
[patent_app_type] => utility
[patent_app_number] => 17/022529
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8864
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17022529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/022529 | Purinone derivative hydrochloride | Sep 15, 2020 | Issued |
Array
(
[id] => 16657360
[patent_doc_number] => 20210053996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => 4-Substituted Benzoxaborole Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/018301
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018301 | 4-substituted benzoxaborole compounds and uses thereof | Sep 10, 2020 | Issued |
Array
(
[id] => 18004914
[patent_doc_number] => 20220363680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => PROCESSES FOR THE SYNTHESIS OF VALBENAZINE
[patent_app_type] => utility
[patent_app_number] => 17/641705
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641705 | PROCESSES FOR THE SYNTHESIS OF VALBENAZINE | Sep 10, 2020 | Pending |
Array
(
[id] => 16990173
[patent_doc_number] => 20210228593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY
[patent_app_type] => utility
[patent_app_number] => 17/014738
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014738
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014738 | METHODS FOR TREATING, DIAGNOSING AND PROGNOSING A HAEMATOLOGICAL MALIGNANCY | Sep 7, 2020 | Abandoned |